• José Luis Campo-Cañaveral de la Cruz, David Gómez de Antonio, Lucas Hoyos-Mejía, Marina Pérez-Redondo, Rosalía Laporta-Hernández, Andrés Varela de Ugarte, and Lung Transplant Unit of the Hospital Universitario Puerta de Hierro-Majadahonda.
• Servicio de Cirugía Torácica, Unidad de Trasplante Pulmonar, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, España. Electronic address: jluiscampo82@gmail.com.
• Arch. Bronconeumol. 2015 Sep 1; 51 (9): e45-7.

AbstractAlthough the number of lung transplants in Spain is increasing annually, more organs are required to ease waiting lists. Controlled non-heart beating donors (NHBD) (Maastricht III) are a reality at international level, and contribute significantly to increasing donor numbers. In this study, we present our NHBD protocol and the initial experience in Spain using lung grafts from this type of donor. Three bilateral lung transplants were performed between January 2012 and December 2014. Preservation was by ex-vivo lung perfusion in 2 cases and by traditional cold ischemia in the other. None of the patients developed grade 3 primary graft dysfunction, no in-hospital mortality was recorded and 1-year survival was 100%. These initial results, and international experience, should help to develop similar protocols to encourage the use of controlled non-heart beating donors.Copyright © 2015 SEPAR. Published by Elsevier Espana. All rights reserved.

12 keywords...

hide…